HOME >> MEDICINE >> NEWS
GroPep awarded key patent for infertility treatment in Europe

Adelaide biotechnology company, GroPep, has achieved a major development milestone in its infertility drug program with the granting of European patent number 1028743.

The patent covering GroPep's drug for the treatment of recurrent miscarriage provides the company with a European market patent exclusivity until at least 2018. GroPep already has two US patents covering the active ingredient of the drug until 2020.

According to the American College of Obstetricians and Gynecologists, at least 50 percent of recurrent miscarriages have no apparent explanation and there is no cure. The size of the market, the lack of competition and the strong patent position held by GroPep, means that the drug has the potential to participate in a market worth up to US$750 million annually.

Listed biopharmaceutical company GroPep Limited (ASX: GRO) today announced that European Patent No. 1028743, covering a method of treating recurrent miscarriage and preeclampsia using GroPep's infertility drug product - PV903, has been granted.

This patent grant is a major product development milestone as it provides the Company with a European market patent exclusivity until at least 2018. The European patent compliments two granted US patents licensed to GroPep by OSI Pharmaceuticals that cover the active ingredient of PV903 and method of manufacture until at least 2020. The combination provides GroPep with patent protection in the world's most valuable markets. The Company is also prosecuting additional patent applications to further extend the patent protection around PV903.

GroPep's Chief Executive Officer, Mr Bob Finder, said that the Company is developing PV903 as a potential treatment for recurrent miscarriage, a traumatic infertility condition with an estimated market potential of over US$750 million per year. There are currently no drugs approved for the treatment of recurrent miscarriage.

The European patent is owned by the Univers
'"/>

Contact: Tony Mitchell
61-88-354-7700
Research Australia
26-Jul-2006


Page: 1 2

Related medicine news :

1. GroPep starts Phase 1 infertility trial
2. GroPep completes final milestone of the path malaria vaccine initiative
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. LSUHSC awarded designation resulting in improved patient safety and outcomes
8. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
9. UIC awarded $7M NIH grant for infertility research
10. $2.6M grant awarded to New York University College of Nursing
11. Greenberg Prize awarded to Dr. Joseph G. Hayes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... April 18, 2019 , ... The Coro Medical official ... Sardis Volunteer Fire Department. , As a small, volunteer-only department in rural Mississippi, ... the community and now, is the only department with life-saving equipment of this caliber ...
(Date:4/18/2019)... , ... April 18, 2019 , ... ... its first ever Cannabis Industry Report . The study—which considers consumers’ perceptions ... intersections with retail and manufacturing, offering insight into what kinds of products consumers ...
(Date:4/17/2019)... ... 17, 2019 , ... Historically, patients have been reluctant to ... changing. Whether because of demographic or generational changes, patients seem to have become ... In the past, efforts to publish performance data about doctors and hospitals were ...
(Date:4/17/2019)... ... April 17, 2019 , ... Ramneek Kumar Talwar and Vineet ... Gwangju, Korea, and has highly evaluated and confirmed iRINGER’s technology, a product that’s ... discussion of a potential partnership since then. , After sharing relevant ...
(Date:4/17/2019)... ... April 17, 2019 , ... Purple Biosciences ... This California-made supplement was designed to lessen the negative effects of alcohol, ... purchase via GotPurpleTree.com and Amazon.com . , According to the ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... 2019 , ... KVC Kentucky will host the 2nd Annual ... horse farm on May 17, 2019 to raise funds to support KVC Kentucky’s ... elegant venue highlights Kentucky's stunning farmland, prized Thoroughbred horses and beautiful equine architecture. ...
(Date:4/17/2019)... , ... April 17, 2019 , ... Salt Lake ... Honorary Doctorate recipients. They will receive their degrees at SLCC’s May 3 Commencement at ... the executive vice president over Corporate Affairs and Miller Family Philanthropy. Richards is president ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... What do ... comedy livestream show? Hosted within the Texas Medical Center’s TMC Innovation Institute, the Healthcare ... 26th, 2019, followed by a review by potential employers — all featured in a ...
Breaking Medicine Technology:
Cached News: